Royal Philips has gained FDA clearance for its new DigitalDiagnost C90 digital radiography system, which features a live video image displayed at the tube head.

Kettering Health Network, an Ohio-based health system, is using AI to reverse the effects of strokes quicker, according to a report by WDTN News.

T2 mapping derived from weekly cardiac MRIs helped researchers identify cardiotoxicity at an early and reversible stage, a finding which may have implications for cancer patients at risk of chemotherapy-induced heart failure.

The Department of Energy’s National Nuclear Security Administration (NNSA) has chosen four U.S. companies to begin negotiations with in an effort to produce Molybdenum-99 (Mo-99) without the use of highly enriched uranium.

A novel PET/CT imaging agent—18F-GP1—produced a high-quality image and yielded a high detection rate for diagnosing acute venous thromboembolism (VTE), reported researchers of a study featured in the February issue of The Journal of Nuclear Medicine.

Stereotactic ablative body radiation therapy (SABR) nearly doubled the overall survival of patients with inoperable stage I lung cancer compared to standard radiotherapy, according to results of a multi-center phase III trial published in the Lancet Oncology.

The FDA has approved nerve stimulation for treatment of episodic and chronic cluster headaches and acute migraines. The findings, detailed in a study published online Feb. 13 in PLOS ONE, could help personalize treatment for PTSD, which according to the National Institute of Mental Health impacts roughly 3.6 percent of U.S. adults per year. 

Researchers at Northwestern University in Chicago have found that, per procedure, using ultrasound with electrocardiography to guide insertions of central venous catheters via the arm is only somewhat less costly than the conventional method, external measurements with confirmatory chest x-rays. However, the savings can add up over time.